Valuation: QuidelOrtho Corporation

Market Cap 571M 521M 479M 436M 819M 52.9B 863M 5.84B 2.32B 28.84B 2.14B 2.1B 90.49B P/E 2026 *
-1.82x
P/E 2027 * -2.32x
Enterprise Value 3.28B 2.99B 2.76B 2.51B 4.71B 304B 4.96B 33.57B 13.33B 166B 12.32B 12.06B 520B EV / Sales 2026 *
1.3x
EV / Sales 2027 * 1.27x
Free-Float
99.08%
Yield 2026 *
-
Yield 2027 * -
1 day-6.73%
1 week-21.66%
Current month-37.21%
1 month-34.80%
3 months-39.71%
6 months-26.89%
Current year-70.87%
1 week 8.06
Extreme 8.06
11.06
1 month 8.06
Extreme 8.06
14.85
Current year 8.06
Extreme 8.06
35.58
1 year 8.06
Extreme 8.06
35.58
3 years 8.06
Extreme 8.06
75.86
5 years 8.06
Extreme 8.06
180.06
10 years 8.06
Extreme 8.06
306.72
Manager TitleAgeSince
Chief Executive Officer 61 06/05/2024
Director of Finance/CFO 48 06/07/2026
Chief Tech/Sci/R&D Officer 44 07/10/2024
Director TitleAgeSince
Chairman 72 11/12/2022
Director/Board Member 71 01/01/2022
Director/Board Member 82 01/01/1993
Date Insider Type Main position Quantity % Market Cap. Importance
15/10/26 Exercice

Chief Technology Officer

44,009 0.0642%
15/09/26 Exercice

Head of Human Resources

6,053 0.0088%
15/08/26 Exercice

EVP Global Port. Mgmt & Mkting

1,054 0.0015% -
Change 5-day change 1-year change 3-year change Capi.($)
-6.73%-21.66%-60.36%-87.44% 612M
-2.79%-4.27%+16.69%+43.55% 255B
-3.16%-5.08%-0.92%+6.05% 160B
-2.01%-9.28%-29.33%+30.72% 141B
-2.35%-5.02%-56.73%-22.75% 62.31B
-1.95%-3.73%+18.40%+52.24% 59.73B
-1.96%-1.92%+3.84%-14.15% 53.49B
-2.83%-1.52%+17.99%+50.58% 49.43B
-3.51%-4.71%+17.06%+68.19% 44.87B
+1.26%-11.97%-2.48%+50.80% 42.57B
Average -2.60%-4.57%-7.58%+17.78% 87B
Weighted average by Cap. -2.44%-3.61%-0.86%+28.79%

Financials

2026 *2027 *
Net sales 2.52B 2.3B 2.12B 1.93B 3.61B 233B 3.81B 25.76B 10.23B 127B 9.45B 9.25B 399B 2.52B 2.29B 2.11B 1.92B 3.61B 233B 3.8B 25.72B 10.21B 127B 9.44B 9.24B 399B
Net income -314M -287M -264M -240M -451M -29.13B -475M -3.21B -1.28B -15.88B -1.18B -1.15B -49.83B -246M -224M -206M -188M -352M -22.77B -372M -2.51B -998M -12.42B -922M -903M -38.96B
Net Debt 2.71B 2.47B 2.28B 2.07B 3.89B 251B 4.1B 27.73B 11.01B 137B 10.18B 9.96B 430B 2.62B 2.39B 2.2B 2B 3.76B 243B 3.97B 26.82B 10.65B 133B 9.84B 9.63B 416B
Projected Income Statement - Annual - QuidelOrtho Corporation
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
20/11/26 $8.320 -6.73% 2,602,567
19/11/26 $8.920 -6.79% 1,915,890
18/11/26 $9.570 -3.04% 2,128,294
17/11/26 $9.870 -3.33% 7,719,583
16/11/26 $10.21 -4.93% 1,943,089
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - QuidelOrtho Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
8.920USD
Average target price
15.00USD
Spread / Average Target
+68.16%
  1. Stock Market
  2. Stocks
  3. QDEL Stock